Manufacturing Chemist Stand Side with Almac Group

Published: 21-Nov-2024 Featured companies: Almac Group

We discover what exhibitors at CPHI Milan 2024 are showcasing LIVE!

Sponsored by Almac Group

In this interview, Manufacturing Chemist Stand Side speaks with Almac Group at CPHI Milan 2024.

For more interviews with leading companies from across the manufacturing pharmaceuticals industry, visit our YouTube channel and hit subscribe.

 

 

Manufacturing Chemist Stand Side...

"Manufacturing Chemist Stand Side" is a series of exclusive video interviews with leading companies in the pharmaceutical industry, conducted during key market events by our award-winning B2B team.

For more information on how you can be part of "Manufacturing Chemist Stand Side" contact Don Phares on +44 207 193 3219 or via email: don@hpcimedia.com.

 

Featured companies

The Almac Group is an established contract development and manufacturing organisation which provides an extensive range of integrated services to the pharmaceutical and biotech...
See more

You may also like

Research & Development

Almac Group announces £11m investment to expand global analytical services

Read more
The Almac Group has announced an £11m investment and the creation of more than 100 new jobs to expand its global analytical services capabilities

Trending Articles

  1. Navigating regulatory challenges in pharmaceutical packaging: lessons from the past and strategies for the future To safeguard drug efficacy, maintain strict quality standards and ensure patient safety, pharmaceutical packaging is subject to a wide range of regulations around the world, reports Kun Shing Chan, Director of QA at Tjoapack
  2. IMA Life and RheaVita team up to commercialise continuous biopharmaceutical freeze-drying tech The companies will work in tandem to develop and commercialise its continuous freeze-drying technology, allowing the rapid production of complex biopharmaceuticals
  3. Transmission Raman Spectroscopy - access the webinar series today Offering significant advantages for bulk, quantitative and non-destructive analysis, Transmission Raman Spectroscopy is a preferred choice for applications where surface analysis is insufficient or prone to errors. Speakers from Agilent, Novartis Pharma, AstraZeneca, Bristol-Myers Squibb and AbbVie go deeper in this FREE webinar series
  4. Sanofi invests €40m into biopharmaceutical manufacturing at its Lyon Gerland site The pharma giant has expanded its French monoclonal antibody production capabilities, while also dedicating €25m to the development of a second-gen polyclonal antibody
  5. IMed supports K2 medical systems in their EU MDR transition Consultancy firm helps K2 navigate the complex regulatory process to achieve Article 97 compliance

Relevant companies

See more

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

You may also like

Research & Development

Almac Group announces £11m investment to expand global analytical services

The Almac Group has announced an £11m investment and the creation of more than 100 new jobs to expand its global analytical services capabilities
Manufacturing

Almac’s Charnwood facility receives FDA approval for oral dose development and manufacturing

The facility, which focuses on the manufacture of high potency oral dosage forms, has been approved for use by the FDA
Research & Development

Why the strategic benefits of outsourcing formulation development matter

The formulation development outsourcing market continues to grow at pace as pharmaceutical companies experience first-hand the strategic advantages that a solid partnership has in terms of driving resource optimisation, accelerating time to market and enhancing competitive advantage
Manufacturing

Almac Sciences awarded Life Sciences Innovative Manufacturing Fund grant

Grant awarded to support the expansion of Almac’s small molecule API manufacturing plant
Design & Build

Almac expands manufacturing, packaging and peptide production capacity with purpose-built facilities

Ongoing Global expansion investment now totals more than £400m
Sustainability

Almac Group signs virtual power purchase agreement for renewable energy

The integration of renewable energy will cut the company’s global scope 2 carbon emissions by 46%
Manufacturing

BGEN awarded small molecule production facility contract by Almac Sciences

This build will enhance Almac Sciences' active pharmaceutical ingredient (API) production capabilities
Subscribe now